Video

Philip R. Schauer, MD, Shares His Thoughts on the Necessary Direction of Accountable Care Organizations

Conference|ADA: American Diabetes Association

Philip R. Schauer, MD, the director of the Bariatric and Metabolic Institute (BMI) at the Cleveland Clinic in Ohio contends that accountable care organizations (ACOs) need to recognize obesity as a legitimate disease that is the basis for many other serious conditions. He emphasizes that obesity certainly requires treatment, and surgery is an appropriate intervention for certain patients.

Philip R. Schauer, MD, the director of the Bariatric and Metabolic Institute (BMI) at the Cleveland Clinic in Ohio contends that accountable care organizations (ACOs) need to recognize obesity as a legitimate disease that is the basis for many other serious conditions. He emphasizes that obesity certainly requires treatment, and surgery is an appropriate intervention for certain patients.

This video was taken at the American Diabetes Associations 73rd Scientific Sessions in Chicago, IL.

Related Videos
Lawrence Eichenfield, MD, FAAD
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Michelle Hessen, OD
Douglas Flora, MD, FACCC
Bridgette J. Picou, LVN, ACLPN, The Well Project
Priscilla Tsondai, MD, MPH, IAS/CIPHER
Mia Moore, PhD, Fred Hutch Cancer Center
Steven Daniel Daveluy, MD, FAAD
Shawn Kwatra, MD, FAAD
Related Content
Doctor supporting disabled patient | Image Credit: © NINENII - stock.adobe.com
March 13th 2025

Regenerating Neurons, Muscle, and Hope in the Field of Muscular Dystrophy

Christina Mattina
The 2025 Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature clinical updates, expert insights, and breaking trial findings that sum up to a new frontier of care for neuromuscular diseases.
Managed Care Cast logo
July 11th 2024

Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Pediatric AD. | Image Credit: Evgeniya Primavera - stock.adobe.com
March 13th 2025

Addressing Financial Aid and Patient Independence as Part of Atopic Dermatitis Care

Cameron Santoro
Discussions centered on mitigating the financial burden of pediatric atopic dermatitis through financial aid programs and enhancing support for young patients to independently manage their condition were emphasized at this year’s 2025 American Academy of Dermatology meeting.
Image of Managed Care Cast logo
August 29th 2023

The Importance of Examining and Preventing Atrial Fibrillation

Maggie L. Shaw
At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
ART | Image credit: gamjai - stock.adobe.com
March 13th 2025

Late-Breaking Antiviral Session Features Phase 3 Results on Efficacy of Doravirine/Islatravir

Julia Bonavitacola
The combination of doravirine plus islatravir was noninferior to bictegravir/emtricitabine/tenofovir alafenamide and oral antiretroviral therapy in patients who switched to doravirine plus islatravir.
Woman holding the HIV/AIDS awareness symbol | Image Credit: fizkes - stock.adobe.com
March 12th 2025

Frailty, Housing Instability Drive Mortality Risk in People With HIV

Brooke McCormick
These abstracts highlight the compounded challenges people with HIV face.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo